Clinical Trials Using BCG Tokyo-172 Strain Vaccine

Clinical trials are research studies that involve people. The clinical trials on this list are studying BCG Tokyo-172 Strain Vaccine. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Different Versions of BCG with or without Vaccine Therapy in Treating Patients with High Grade Bladder Cancer That Is Not Muscle Invasive

    This randomized phase III trial studies bacillus Calmette-Guerin (BCG) Tokyo-172 strain solution with or without a vaccination, BCG Tokyo-172 strain vaccine, to see how well it works compared with BCG solution in treating patients with bladder cancer that has not spread to muscle. BCG is a weakened form of the bacterium Mycobacterium bovis that does not cause disease. BCG is used in a solution to stimulate the immune system in the treatment of bladder cancer. Giving different versions of BCG with vaccine therapy may prevent bladder cancer from returning.
    Location: 139 locations